The page is the record's research on the issuer — no analyst, no rating, no view. # Hansa Biopharma AB (Nasdaq Stockholm: SE0002148817) — research page As of 2026-11-11 · se-cm-kg · record version 1 ## Identity and listing The issuer is Hansa Biopharma AB, listed on Nasdaq Stockholm, with ticker SE0002148817 and ISIN SE0002148817, and LEI 549300LLEO25ZJJ3NT91. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 112 filings in the twelve months to 2026-11-11, across 53 filing days. The median gap between filing days is 5.0 days, against a median of 9.5 days for the 398 issuers on Nasdaq Stockholm. The median filing count for the exchange is 30.0. The latest filing is dated 2026-11-11 and is of type Interim report (Q1 and Q3), and the days from latest filing to record date are 0, against an exchange median of 7.0 days. The sector median is not on the record. ## Auditor The auditor of record and its location are not on the record. Auditor changes are not on the record, as the lifecycle type map for this register is not yet available. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as the index does not carry a lifecycle type for this register. The halt flag reads listed, not halted. ## Orderability The orderability outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04. ## Coverage The record names nine research houses on the issuer's investor-relations page: SEB, ABG Sundal Collier, Van Lanschot Kempen, Carnegie, H.C. Wainwright & Co., William Blair, Leerink Partners LLC, Jefferies LLC and Wedbush Securities. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://firds.esma.europa.eu/firds/ (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.se-cm-kg.ai/events/XSTO/SE0002148817 (the disclosure lines) - https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag) - https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.hansabiopharma.com/investors/analysts/ (coverage) - https://mcp.se-cm-kg.ai/record/XSTO/SE0002148817 (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/se/XSTO/SE0002148817 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp